Feasibility of methionine oxidation quantification in proteins through Raman and FT-IR spectroscopy
The development of biopharmaceuticals poses unique challenges, with alterations of chemical integrity potentially impairing product efficacy and safety. Thus, oxidation-susceptibility of drug candidates is typically assessed by chromatographic methods, potentially coupled with mass spectrometry (LC-MS), which enable residue-specific oxidation monitoring but require high-resolution instrumentation, specialized expertise, and may introduce sample preparation artefacts. These constraints have raised interest in orthogonal, simple and fast methods to probe oxidation in native protein samples. Raman and Fourier transform infrared spectroscopy (FT-IR) have shown potential for detecting methionine oxidation, the most common oxidative protein liability. The aim of this work was to transfer the known quantification potential of cuvette-based Raman spectroscopy to Raman microscopy and evaluate its suitability for high-throughput screenings. Following several technical optimizations, this work shows that the detection of oxidation by Raman microscopy could only be confirmed for molecular methionine in solution and not for proteinogenic methionine. In contrast, liquid-cell FT-IR enabled solid quantitative read-outs of methionine oxidation in proteins. Under the investigated forced degradation conditions, the method showed good agreement to orthogonal LC-MS measurements utilizing the multi-attribute method (MAM). These findings position liquid-cell FT-IR as a potential rapid, low-volume screening tool for oxidation assessments in native protein samples, particularly during early-stage biopharmaceutical development.
Authors
- Christoph Haisch (ORCID: https://orcid.org/0000-0002-6344-6750)
- Wolfgang Frieß (ORCID: https://orcid.org/0000-0002-8807-309X)
- Patrick Sascha Merkle (ORCID: https://orcid.org/0000-0002-1409-5747)
- Ingo Fischer (ORCID: https://orcid.org/0000-0001-8978-4013)
- Karoline Bechtold-Peters (ORCID: https://orcid.org/0000-0001-7451-3819)
- Adam A. Sobczuk
- François Griaud (ORCID: https://orcid.org/0000-0002-2803-8102)
- Malak Bitar
- Patrick Kubryk (ORCID: https://orcid.org/0000-0002-3135-5002)
- Victor Le-Minh
- Eva Krois (ORCID: https://orcid.org/0000-0003-0456-3663)
- Manuela Gritsch
- Marco Venerito
- Thorben Höltkemeier (ORCID: https://orcid.org/0009-0009-5409-9097)
Institutions
- Novartis (Switzerland) (CH)
- Renishaw (United Kingdom) (GB)
- Technical University of Munich (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.64898/2026.11.18.767667
- Primary Topic
- Spectroscopy Techniques in Biomedical and Chemical Research
- Type
- preprint